Blockchain Registration Transaction Record
Innovative TABK Antibody Targets NK Cells & Tumors Simultaneously
Discover how the TABK antibody targets NK cells & tumors simultaneously, a breakthrough in cancer research by Creative Biolabs, highlighting cell line development's role.

This news is pivotal for the biotech and pharmaceutical industries, as the development of the TABK antibody represents a significant leap forward in cancer treatment research. By simultaneously targeting NK cells and tumor cells, this innovation could lead to more effective therapies. Additionally, Creative Biolabs' emphasis on cell line development and stability underscores the foundational role of quality control in biotech advancements, impacting future drug development and therapeutic strategies.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0x322ad2ee2e4213c17dac448960e98ab8c8aa9ada0c9a72f94b2e8b2adee00e57 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | poemRAuL-a70afbe190276068bbb6a28b30bb9ff7 |